These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 9774881)
1. [Acute pain due to vinorelbine]. Cabrera Rodríguez J; Muñoz García J Rev Clin Esp; 1998 Aug; 198(8):514-6. PubMed ID: 9774881 [TBL] [Abstract][Full Text] [Related]
2. Acute tumor pain in patients with head and neck cancer treated with vinorelbine. Kornek GV; Kornfehl H; Hejna M; Raderer M; Zöchbauer S; Scheithauer W J Natl Cancer Inst; 1996 Nov; 88(21):1593. PubMed ID: 8901858 [No Abstract] [Full Text] [Related]
3. Vinorelbine and carboplatin in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Kornek V; Scheithauer W; Glaser C; Toth J; Duman M; Formanek M; Hejna M; Kornfehl J Oncology; 1999; 56(1):24-7. PubMed ID: 9885373 [TBL] [Abstract][Full Text] [Related]
4. Cisplatin plus vinorelbine for patients with advanced head and neck squamous cell carcinoma. Segura A; Pastor M; Santaballa A; Yuste A; López P; Aparicio J Oncologist; 2000; 5(2):177-8. PubMed ID: 10794811 [No Abstract] [Full Text] [Related]
5. Neoadjuvant carboplatin and vinorelbine followed by chemoradiotherapy in locally advanced head and neck or oesophageal squamous cell carcinoma: a phase II study in elderly patients or patients with poor performance status. Koussis H; Scola A; Bergamo F; Tonello S; Basso U; Karahontzitis P; Chiarion-Sileni V; Pasetto L; Ruol A; Loreggian L; Lora O; Bottin R; Marioni G; Donach M; Jirillo A Anticancer Res; 2008; 28(2B):1383-8. PubMed ID: 18505084 [TBL] [Abstract][Full Text] [Related]
6. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer. Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230 [TBL] [Abstract][Full Text] [Related]
7. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study. Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237 [TBL] [Abstract][Full Text] [Related]
8. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer. Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239 [TBL] [Abstract][Full Text] [Related]
9. A new concurrent chemotherapy with vinorelbine and mitomycin C in combination with radiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck. Wilkowski R; Pachmann S; Schymura B; Dellian M; Schalhorn A; Dühmke E Onkologie; 2005 Oct; 28(10):491-5. PubMed ID: 16160398 [TBL] [Abstract][Full Text] [Related]
10. Does pain at tumor site during vinorelbine infusion affect treatment of recurrent head and neck cancer patients? De Marco S; Fabi A; Ceribelli A; Carlini P; Pollera CF; Cognetti F Ann Oncol; 1999 Jul; 10(7):865-6. PubMed ID: 10470437 [No Abstract] [Full Text] [Related]
11. Re: Severe neurotoxicity in vinorelbine-paclitaxel combinations. Budman DR; Weiselberg L; O'Mara V J Natl Cancer Inst; 1997 Jan; 89(1):87-8. PubMed ID: 8978412 [No Abstract] [Full Text] [Related]
12. Pain at tumor site after vinorelbine injection: description of an unexpected side effect. Colleoni M; Gaion F; Vicario G; Nelli P; Pancheri F; Sgarbossa G; Manente P Tumori; 1995; 81(3):194-6. PubMed ID: 7571027 [TBL] [Abstract][Full Text] [Related]
13. [Oral vinorelbine: pharmacology and treatment outcome in non-small cell bronchial carcinoma and breast carcinoma]. Bartsch V Onkologie; 2006 Mar; 29 Suppl 1():1-28. PubMed ID: 16534241 [TBL] [Abstract][Full Text] [Related]
15. Dose escalation of oral vinorelbine in combination with estramustine in hormone-refractory adenocarcinoma of the prostate. Mackler NJ; Dunn RL; Hellerstedt B; Cooney KA; Fardig J; Olson K; Pienta KJ; Smith DC Cancer; 2006 Jun; 106(12):2617-23. PubMed ID: 16691618 [TBL] [Abstract][Full Text] [Related]
16. Ex vivo responsiveness of head and neck squamous cell carcinoma to vinorelbine. Dollner R; Granzow C; Tschop K; Dietz A Anticancer Res; 2006; 26(3B):2361-5. PubMed ID: 16821617 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel in combination with vinorelbine in pretreated advanced breast cancer patients. Michelotti A; Gennari A; Salvadori B; Giannessi PG; Baldini E; Tibaldi C; Da Prato M; Conte PF Semin Oncol; 1996 Oct; 23(5 Suppl 11):38-40. PubMed ID: 8893898 [TBL] [Abstract][Full Text] [Related]
18. Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines. Erjala K; Raitanen M; Kulmala J; Grénman R J Cancer Res Clin Oncol; 2007 Mar; 133(3):169-76. PubMed ID: 17021904 [TBL] [Abstract][Full Text] [Related]
19. A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck. Espinosa E; Zamora P; Millá A; Morales S; Molina R; Mira M; González Barón M; Head Neck; 2002 Dec; 24(12):1054-9. PubMed ID: 12454943 [TBL] [Abstract][Full Text] [Related]
20. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results. Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]